AZoRobotics highlights the new digital pathology and artificial intelligence advancements between Lumea and Tempus on their website.
More advancements are happening between pathology and artificial intelligence every year. This one is particularly exciting because Tempus will use Lumea’s software to develop algorithms that will have the potential to screen cancer patients. This will identify patients who would benefit from molecular profiling and may qualify for targeted therapies.
AZoRobotics educates and informs a worldwide audience of researchers, engineers and scientists with the latest industry news, information and insights from the Robotics industry.